| ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers K Bergethon, AT Shaw, SH Ignatius Ou, R Katayama, CM Lovly, ... Journal of clinical oncology 30 (8), 863-870, 2012 | 2005 | 2012 |
| LKB1 modulates lung cancer differentiation and metastasis H Ji, MR Ramsey, DN Hayes, C Fan, K McNamara, P Kozlowski, C Torrice, ... Nature 448 (7155), 807-810, 2007 | 1201 | 2007 |
| Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth AMG Houghton, DM Rzymkiewicz, H Ji, AD Gregory, EE Egea, HE Metz, ... Nature medicine 16 (2), 219-223, 2010 | 837 | 2010 |
| RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–Small-Cell Lung Cancer R Wang, H Hu, Y Pan, Y Li, T Ye, C Li, X Luo, L Wang, H Li, Y Zhang, F Li, ... Journal of clinical oncology 30 (35), 4352-4359, 2012 | 646 | 2012 |
| A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer S Jiao, H Wang, Z Shi, A Dong, W Zhang, X Song, F He, Y Wang, Z Zhang, ... Cancer cell 25 (2), 166-180, 2014 | 644 | 2014 |
| The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies H Ji, D Li, L Chen, T Shimamura, S Kobayashi, K McNamara, U Mahmood, ... Cancer cell 9 (6), 485-495, 2006 | 542 | 2006 |
| High-resolution genomic profiles of human lung cancer G Tonon, KK Wong, G Maulik, C Brennan, B Feng, Y Zhang, DB Khatry, ... Proceedings of the National Academy of Sciences 102 (27), 9625-9630, 2005 | 475 | 2005 |
| Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression C Xu, CM Fillmore, S Koyama, H Wu, Y Zhao, Z Chen, GS Herter-Sprie, ... Cancer cell 25 (5), 590-604, 2014 | 393 | 2014 |
| Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases Y Sun, Y Ren, Z Fang, C Li, R Fang, B Gao, X Han, W Tian, W Pao, ... Journal of clinical oncology 28 (30), 4616-4620, 2010 | 386 | 2010 |
| VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex W Zhang, Y Gao, P Li, Z Shi, T Guo, F Li, X Han, Y Feng, C Zheng, ... Cell research 24 (3), 331-343, 2014 | 332 | 2014 |
| Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors H Ji, X Zhao, Y Yuza, T Shimamura, D Li, A Protopopov, BL Jung, ... Proceedings of the National Academy of Sciences 103 (20), 7817-7822, 2006 | 324 | 2006 |
| An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor S Kobayashi, H Ji, Y Yuza, M Meyerson, KK Wong, DG Tenen, B Halmos Cancer research 65 (16), 7096-7101, 2005 | 318 | 2005 |
| K-ras activation generates an inflammatory response in lung tumors H Ji, AM Houghton, TJ Mariani, S Perera, CB Kim, R Padera, G Tonon, ... Oncogene 25 (14), 2105-2112, 2006 | 311 | 2006 |
| YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression Y Shi, S Fan, M Wu, Z Zuo, X Li, L Jiang, Q Shen, P Xu, L Zeng, Y Zhou, ... Nature communications 10 (1), 4892, 2019 | 308 | 2019 |
| MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene R Fang, T Xiao, Z Fang, Y Sun, F Li, Y Gao, Y Feng, L Li, Y Wang, X Liu, ... Journal of Biological Chemistry 287 (27), 23227-23235, 2012 | 295 | 2012 |
| YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis X Zhou, W Li, S Wang, P Zhang, Q Wang, J Xiao, C Zhang, X Zheng, X Xu, ... Cell reports 27 (4), 1176-1189. e5, 2019 | 293 | 2019 |
| Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression H Ji, G Liao, WA Faubion, AC Abadía-Molina, C Cozzo, FS Laroux, ... The Journal of Immunology 172 (10), 5823-5827, 2004 | 287 | 2004 |
| Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth Y Yin, X Cai, X Chen, H Liang, Y Zhang, J Li, Z Wang, X Chen, W Zhang, ... Cell research 24 (10), 1164-1180, 2014 | 281 | 2014 |
| Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy D Li, T Shimamura, H Ji, L Chen, HJ Haringsma, K McNamara, MC Liang, ... Cancer cell 12 (1), 81-93, 2007 | 275 | 2007 |
| Personalized characterization of diseases using sample-specific networks X Liu, Y Wang, H Ji, K Aihara, L Chen Nucleic acids research 44 (22), e164-e164, 2016 | 273 | 2016 |
Xiangkun HanResearch fellow, Harvard Medical SchoolVerified email at hms.harvard.edu
